Uploaded July 2012 | Updated September 2026, 1 week ago
Board-certified dermatologist Dr. Steven Shapiro, discusses the findings from TriPollar's FDA clinical trial. As the principal investigator for the FDA study and one of the first physicians in the US to use TriPollar, Dr. Shapiro has treated hundreds of patients and addresses the results, safety profile and patient satisfaction experienced both in the trial and in his own practice.
Board-certified dermatologist Dr. Steven Shapiro, discusses the findings from TriPollar's FDA clinical trial. As the principal investigator for the FDA study and one of the first physicians in the US to use TriPollar, Dr. Shapiro has treated hundreds of patients and addresses the results, safety profile and patient satisfaction experienced both in the trial and in his own practice.
